| |
| |
|
| Insider
Information: |
Riker Lauren Bullaro |
| Relationship: |
Senior Vice President,... |
| City: |
Parsippany |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
22,528 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$662,774 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
22,528 |
|
|
| Total
Value |
$662,774 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
13
|
|
Stock
price went up :
|
0
|
7
|
| Stock
price went down : |
0
|
6
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.2
|
| Percentage
Gain/Loss : |
0.0%
|
 133.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pacira Pharmaceuticals, Inc. |
PCRX |
Senior Vice President,... |
2024-01-02 |
22,528 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
74 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2019-11-20 |
4 |
OE |
$10.81 |
$10,810 |
D/D |
1,000 |
11,640 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2019-11-20 |
4 |
S |
$44.14 |
$51,909 |
D/D |
(1,176) |
10,464 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2019-12-23 |
4 |
AS |
$45.92 |
$45,920 |
D/D |
(1,000) |
10,464 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2019-12-23 |
4 |
OE |
$10.81 |
$10,810 |
D/D |
1,000 |
11,464 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2020-02-06 |
4 |
OE |
$10.81 |
$8,972 |
D/D |
830 |
11,294 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2020-02-06 |
4 |
AS |
$46.81 |
$38,852 |
D/D |
(830) |
10,464 |
0 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2020-02-07 |
4 |
OE |
$10.81 |
$1,838 |
D/D |
170 |
10,634 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2020-02-07 |
4 |
AS |
$46.81 |
$7,958 |
D/D |
(170) |
10,464 |
0 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2020-02-10 |
4 |
AS |
$47.81 |
$146,430 |
D/D |
(3,000) |
10,464 |
0 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2020-02-10 |
4 |
OE |
$10.81 |
$32,430 |
D/D |
3,000 |
13,464 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2020-05-19 |
4 |
OE |
$10.34 |
$20,680 |
D/D |
2,000 |
12,464 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2020-05-19 |
4 |
S |
$42.81 |
$85,620 |
D/D |
(2,000) |
10,464 |
0 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2020-05-21 |
4 |
S |
$45.26 |
$90,520 |
D/D |
(2,000) |
10,464 |
0 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2020-05-21 |
4 |
OE |
$10.34 |
$20,680 |
D/D |
2,000 |
12,464 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2020-06-04 |
4 |
S |
$46.33 |
$40,725 |
D/D |
(879) |
9,585 |
0 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2020-06-05 |
4 |
S |
$48.37 |
$84,744 |
D/D |
(1,752) |
7,833 |
0 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2020-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
4,800 |
12,633 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2020-06-29 |
4 |
OE |
$10.34 |
$62,040 |
D/D |
6,000 |
18,633 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2020-06-29 |
4 |
AS |
$48.72 |
$296,800 |
D/D |
(6,000) |
12,633 |
0 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2020-08-11 |
4 |
OE |
$10.34 |
$84,581 |
D/D |
8,180 |
20,813 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2020-08-11 |
4 |
S |
$60.50 |
$494,890 |
D/D |
(8,180) |
13,181 |
0 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2020-09-16 |
4 |
AS |
$60.34 |
$181,020 |
D/D |
(3,000) |
13,181 |
0 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2020-09-16 |
4 |
OE |
$10.81 |
$32,430 |
D/D |
3,000 |
16,181 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2020-11-13 |
4 |
OE |
$10.81 |
$32,430 |
D/D |
3,000 |
16,181 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Vice President, Finance |
• – – |
2020-11-13 |
4 |
AS |
$63.81 |
$191,430 |
D/D |
(3,000) |
13,181 |
0 |
% |
|
74 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
